# Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer

> **NCT00880464** · PHASE1 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 8 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** Autologous, Lethally Irradiated Breast Cancer Cells

## Key facts

- **NCT ID:** NCT00880464
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01-01
- **Primary completion:** 2011-10
- **Final completion:** 2021-06
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2022-04-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880464, "Autologous Vaccination With Lethally Irradiated, Autologous Breast Cancer Cells Engineered to Secrete GM-CSF in Women With Operable Breast Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00880464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*